REMED's largest shareholder Geunyong Lee and related parties report change in stock collateral loans… 19.76% of total shares pledged, posing forced selling risk if stock price drops
The largest shareholder Geunyong Lee and 10 specially related persons have pledged 6,105,940 shares (19.76% of total) out of their 11,166,076 shares (36.12% stake) as collateral to multiple securities firms (Lee: 4,276,834 shares, related parties: 1,829,106 shares)
Total collateral loan amount is approximately 10.14 billion KRW (Lee: 6.75B, Hong Seong-pil: 2.0B, Lee Sang-yong: 1.39B), with maintenance ratios of 150%~200%, posing risk of margin calls or forced selling if stock price falls sharply
This report is a routine disclosure reflecting changes in existing collateral agreements (some contract extensions and new contracts), with no change in total shares held
[AI Comprehensive Analysis]The high pledge ratio (19.76%) is a potential risk factor that could affect management control in case of stock price decline. However, this disclosure does not involve new fundraising or equity dilution, and transparently discloses changes in collateral agreements. Investors should closely monitor the possibility of margin maintenance given future price volatility.